Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Multiple Myeloma × treosulfan × Clear all

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 3 Leukemia, Myeloid, Acute 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Prolymphocytic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Hodgkin Disease 1 Burkitt Lymphoma 1

Interventions

Dexamethasone 86 Lenalidomide 51 daratumumab 50 Bortezomib 32 pomalidomide 30 Cyclophosphamide 30 carfilzomib 24 Calcium Dobesilate 23 talquetamab 19 fludarabine 19 Magnetic Resonance Spectroscopy 17 iberdomide 16 Specimen Handling 15 Biopsy 15 isatuximab 14 belantamab mafodotin 12 selinexor 11 Melphalan 11 dexamethasone acetate 10 elotuzumab 9 dexamethasone 21-phosphate 9 auricularum 8 venetoclax 6 X-Rays 6 tocilizumab 5 fludarabine phosphate 5 Blood Specimen Collection 5 ruxolitinib 4 ixazomib 4 Methylprednisolone 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05636787 2024-07-08

TreoMel

Insel Gruppe AG, University Hospital Bern

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡